Network and Transcriptomic Integration Identifies PGC-1α as a Central Node of the 3,5-Diiodo-L-Thyronine–Responsive Metabolic Network in Metabolic Dysfunction-Associated Steatotic Liver Disease
Year: 2026
Type: preprint
Abstract: Objective To characterize the network-level relationship between curated 3,5-T2 targets and the MASLD interactome and identify mechanistic hubs supported by human hepatic transcriptomics. Methods Seventeen experimentally supported 3,5-T2 targets were integrated with a 187-gene MASLD set curated from GeneCards, DisGeNET, and OMIM. High-confidence protein–protein interactions were constructed using STRING, followed by Cytoscape/cytoHubba topological analysis and pathway enrichment. Hub-gene expression was independently evaluated in human liver datasets GSE89632 and GSE126848. Results Six of 17 3,5-T2 targets overlapped the MASLD interactome. The merged network comprised 182 connected proteins and 1,268 high-confidence interactions, demonstrating marked PPI enrichment (p < 10⁻¹⁶). PPARGC1A (PGC-1α) was the only 3,5-T2 target qualifying as a network hub, ranking seventh by degree and third by betweenness. The network significantly reconstructed NAFLD, AMPK, and PPAR signaling (all FDR < 10⁻¹⁹). PPARGC1A was concordantly repressed in both human cohorts (log2FC − 0.78 and − 0.84; FDR < 10⁻⁵), identifying it as the principal topological and transcriptional bottleneck. Conclusion Network and transcriptomic convergence supports 3,5-T2 as a polypharmacological modulator of the AMPK–PGC-1α–UCP metabolic axis in MASLD rather than a single-receptor agonist, providing a mechanistic framework for experimental validation and mechanistic refinement.
Source: Research Square
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7204169538
